Kite to Report Second Quarter 2017 Financial Results on August 8, 2017

08:30 EDT 1 Aug 2017 | Businesswire
Kite Pharma, Inc.

Conference Call and Webcast Scheduled for 8:30 AM ET / 5:30 AM PT

Kite Pharma, Inc. (Nasdaq:KITE), a leading cell therapy company, today announced that it will report second quarter 2017 financial results on Tuesday, August 8, 2017, prior to the open of U.S. based financial markets. The announcement will be followed by a live audio webcast and conference call at 8:30 AM ET / 5:30 AM PT.

Audio Webcast

The webcast will be made available on the Company's website at under the Investors tab in the Events and Presentations section. Following the live audio webcast, a replay will be available on the Company's website for approximately 30 days.

Dial-In Information

Live (U.S. / Canada): (888) 771-4371
Live (International): (847) 585-4405
Confirmation number: 45253546

About Kite

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit Sign up to follow @KitePharma on Twitter at

Kite Contacts:
Christine Cassiano
SVP, Corporate Communications & Investor Relations
Greg Mann
VP, Investor Relations


More From BioPortfolio on "Kite to Report Second Quarter 2017 Financial Results on August 8, 2017"

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...